ICCM — Icecure Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $66.19m
- $58.62m
- $3.29m
Annual cashflow statement for Icecure Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.73 | -9.89 | -17 | -14.7 | -15.3 |
| Depreciation | |||||
| Non-Cash Items | -0.223 | 0.321 | 2.22 | 1.26 | 0.908 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.2 | -3.16 | 0.214 | 0.523 | 1.51 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.69 | -12.6 | -14.3 | -12.6 | -12.6 |
| Capital Expenditures | -0.223 | -0.533 | -0.891 | -0.48 | -0.071 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.45 | 4.33 | 0 | -0.204 | 0.517 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.67 | 3.79 | -0.891 | -0.684 | 0.446 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 5.86 | 30.9 | 13.6 | 0.083 | 9.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.29 | 22.1 | -1.96 | -13.1 | -2.97 |